EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Is transvaginal mesh surgery with polytetrafluoroethylene mesh ORIHIME ® feasible for anterior pelvic organ prolapse?—Randomized comparative study between ORIHIME ® and Polyform™

Masami Takeyama iD, Tomoko Kuwata iD, Hiromi Kashihara, Chikako Kato, Masaki Watanabe iD

International Journal of Urology · 2024

DOI: 10.1111/iju.15506 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Masami Takeyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Urogynecology Center, First Towakai Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Polytetrafluoroethylene, Pelvic Organ Prolapse, Surgical Mesh, Feasibility Studies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Transvaginal mesh surgery for pelvic organ prolapse has been widely performed in Japan, but polypropylene mesh has not been used in Japan since the ban on TVM using polypropylene mesh in the United States. Currently, polytetrafluoroethylene mesh ORIHIME® is the only mesh available for TVM in Japan. Although polytetrafluoroethylene is a safe material, its low coefficient of friction and insufficient adhesion to the surrounding tissue make it difficult to maintain the mesh position when it is used in the transvaginal mesh surgery. The aim of this study was to evaluate the feasibility of TVM‐A2 using ORIHIME®.

Methods

One hundred cases of TVM‐A2 were included in the study. The patients were randomly assigned to two groups: the ORIHIME® group (Group O) and the Polyform TM group (Group P). With 50 patients in each group, the complications and recurrences up to the fourth year were compared. Surgeries were performed using the TVM‐A2 method. Statistical analysis was performed using EZR.

Results

There were no significant differences in baseline parameters between the two groups. We observed no perioperative complications, and saw one case of postoperative abscess formation in Group O, which resolved successfully after incision and drainage. The 4‐year recurrence rate was significantly higher in Group O.

Conclusion

As the recurrence rate was significantly higher in Group O, we conclude that TVM‐A2 using ORIHIME® which is the same procedure as TVM‐A2 using polypropylene mesh is not feasible in repairing the pelvic organ prolapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolytetrafluoroethylenePelvic Organ ProlapseSurgical MeshFeasibility StudiesHumansFemaleAgedMiddle AgedPostoperative ComplicationsJapanRecurrenceTreatment Outcome

Stichwörter der Autor:innen

PTFE meshcomparative studyobjective recurrence ratespelvic organ prolapsetrans‐vaginal mesh

Substanzen

Polytetrafluoroethylene

Autor:innen und Institutionen

  • Urogynecology Center, First Towakai Hospital, Osaka, Japan.
  • Urology Department, Kitasaito Hospital, Asahikawa, Hokkaido, Japan.

ORCID-Profile: Masami Takeyama, Tomoko Kuwata, Masaki Watanabe

Zitieren

APA

Takeyama, M., Kuwata, T., Kashihara, H., Kato, C., & Watanabe, M. (2024). Is transvaginal mesh surgery with polytetrafluoroethylene mesh ORIHIME ® feasible for anterior pelvic organ prolapse?—Randomized comparative study between ORIHIME ® and Polyform™. International Journal of Urology. https://doi.org/10.1111/iju.15506

Vancouver

Takeyama M, Kuwata T, Kashihara H, Kato C, Watanabe M. Is transvaginal mesh surgery with polytetrafluoroethylene mesh ORIHIME ® feasible for anterior pelvic organ prolapse?—Randomized comparative study between ORIHIME ® and Polyform™. International Journal of Urology. 2024. doi:10.1111/iju.15506

BibTeX
@article{Takeyama2024,
  author = {Takeyama, Masami and Kuwata, Tomoko and Kashihara, Hiromi and Kato, Chikako and Watanabe, Masaki},
  title = {Is transvaginal mesh surgery with polytetrafluoroethylene mesh ORIHIME ® feasible for anterior pelvic organ prolapse?—Randomized comparative study between ORIHIME ® and Polyform™},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15506}
}
Kostenlos starten →